TRIB - Trinity Biotech GAAP EPADS of -50c revenue of $18.78M misses by $1.22M June, 30 2022 09:14 AM Trinity Biotech plc Trinity Biotech press release ( NASDAQ: TRIB ): Q1 GAAP EPADS of -50c. Revenue of $18.78M (-26.6% Y/Y) misses by $1.22M . For further details see: Trinity Biotech GAAP EPADS of -50c, revenue of $18.78M misses by $1.22M